NCT05747456 (FaceHyal) is a NA clinical trial of IPN-21-SENSE in Volume Deficiency in the Mid-Face, sponsored by Laboratoires Vivacy.

Who is sponsoring NCT05747456?

NCT05747456 is sponsored by Laboratoires Vivacy.

What drugs are being tested in NCT05747456?

Interventions in NCT05747456: IPN-21-SENSE, IPN-21-SENSE.

What condition does NCT05747456 study?

NCT05747456 studies Volume Deficiency in the Mid-Face, Aging, Aesthetics.

Is NCT05747456 still recruiting?

NCT05747456 is currently completed. Last updated 10 September 2025.

Last reviewed 2025-09-10 · How we verify

NCT05747456: FaceHyal

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal)

Completed NA Last updated 10 September 2025

What this trial tests

NA trial testing IPN-21-SENSE in Volume Deficiency in the Mid-Face in 89 participants. Completed in 2 September 2025.

Timeline

22 February 2023

Primary endpoint
30 April 2024

2 September 2025

Quick facts

Lead sponsor	Laboratoires Vivacy
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	89
Start date	22 February 2023
Primary completion	30 April 2024
Estimated completion	2 September 2025
Sites	1 location across France

Drugs / interventions tested

IPN-21-SENSE
IPN-21-SENSE

Conditions studied

Volume Deficiency in the Mid-Face — all drugs for Volume Deficiency in the Mid-Face →
Aging — all drugs for Aging →
Aesthetics — all drugs for Aesthetics →

Sponsor

Laboratoires Vivacy

Who can join

Adults 30 to 84, any sex, with Volume Deficiency in the Mid-Face or Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the study is to demonstrate the superiority of IPN-21-SENSE versus no treatment at 24 weeks after baseline for the creation or restoration of volume deficit in the mid-face.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Laboratoires Vivacy trials

Trials by the same sponsor.

NCT05809739 — Effectiveness and Safety of STYLAGE® HYDRO in the Treatment of Face, Neckline Area and Neck · NA · completed
NCT05355454 — Study of STYLAGE® XXL for Volume Deficiency in the Mid-Face · NA · completed
NCT05146310 — Prospective, Multicenter, Non-comparative Clinical Investigation to Support Safety & Effectiveness of I.SPACE® · NA · completed
NCT05087732 — Effectiveness and Safety of STYLAGE® M LIDOCAINE Versus STYLAGE® M in Filling Nasolabial Folds · NA · completed
NCT05009381 — Effectiveness and Safety of STYLAGE® XXL for Chin Augmentation in Chinese Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05747456 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Laboratoires Vivacy
Last refreshed: 10 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05747456.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing